Mental Health Clinics in Audubon, PA Accepting Medicare
2 Mental Health Clinics found. Showing 1 - 2
 Tlc Wellness Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1100 Adams Ave Ste 100, Audubon, PA 19403 Phone: 610-389-9090 |
Anchored Counseling Solutions Llc Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 2722 Apple Valley Ln, Audubon, PA 19403 Phone: 907-299-0059 |
News Archive
Risk of depression, anxiety found to be higher among adults with cerebral palsy
Adults with cerebral palsy have a higher risk of developing depression and anxiety than their peers without the condition, a new study in the journal JAMA Neurology reports.
New genome-wide study identifies causes of serious childhood immune disorder
A new genomics study, led by the Center for Applied Genomics at The Children's Hospital of Philadelphia, sets the stage for the first predictive diagnostic test in a serious immunodeficiency disease in children. If the disorder, common variable immunodeficiency disease, can be diagnosed early, children may receive life-saving treatments before the disease can progress.
Psychologist offers a family guide to help a loved one with OCD
When a loved one has Obsessive-Compulsive Disorder (OCD), it's a constant struggle. It hurts to see your spouse so anxious or your teen spending so much time alone.
Delaying delivery by a few days is as effective as immediate delivery for babies who have experienced fetal trauma
Results of a European study in this week's issue of THE LANCET suggest that delaying delivery by a few days is as effective as immediate delivery for babies who have experienced fetal trauma. The study also showed that fetuses delivered without delay at 30 weeks or younger had an increased risk of infant disability compared with delayed delivery.
Positive results from Ardea Biosciences' Phase 2b study of RDEA594 for hyperuricemia and gout
Ardea Biosciences, Inc. announced positive, preliminary, top-line results from its Phase 2b monotherapy study of RDEA594, its lead product candidate for the treatment of hyperuricemia and gout. In this 28-day, randomized, double-blind, placebo-controlled, dose-escalation study, 123 gout patients with hyperuricemia (serum urate levels greater than or equal to 8 mg/dL) received 200 mg once-daily (qd) RDEA594, 400 mg qd RDEA594, 600 mg qd RDEA594 or matching placebo.
› Verified 2 days ago